Ozempic has been approved for type-2 diabetes, while Novo Nordisk’s other global blockbuster Wegovy is targeted at obesity.
The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...
ROURKELA: National Institute of Technology Rourkela (NIT Rourkela) innovators have developed a robotic system designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback